We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cangene Strikes new Deal with Apotex to Commercialize Certain Biotech Drugs

News   Apr 17, 2009

 
Cangene Strikes new Deal with Apotex to Commercialize Certain Biotech Drugs
 
 
 

RELATED ARTICLES

“Semi-synthetic” Bacteria Churn Out Proteins Containing Unnatural Amino Acids

News

Researchers have optimized a semi-synthetic bacteria to efficiently produce proteins containing unnatural amino acids.

READ MORE

Protein Gives Identical Cells Individuality

News

New insight into a protein's role in regulating tight DNA packing could have implications for combating tumor cell resistance to anti-cancer treatments.

READ MORE

Marathon-running Molecule Set to Accelerate the Race for Novel Neurological Drugs

News

Two proteins that activate the fastest molecule in our nerve cells have been identified by researchers at University of Warwick. This mechanism is responsible for transport through our nervous system. This finding could lead to a new therapeutic treatments for people with hereditary spastic paraplegia and other neurological disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE